AIFinancial Timesabout 7 hours ago

ICON selects Microsoft for AI clinical development

1 min read

ICON selected Microsoft as a preferred technology partner to power AI-enabled clinical development. The partnership aims to leverage Microsoft's cloud and AI capabilities to accelerate clinical trials and drug development processes for ICON's clients.

Level

Hype check

Tap to vote and see what everyone thinks.

In this storyMicrosoft